Provenance Global Trade Network LLC
The entity operating this website and the Provenance commercial-origination service.
About Provenance
Know the role before you share the requirement.
Provenance Global Trade Network LLC is a buyer-led, non-custodial commercial-origination and market-access business for regulated medical-cannabis trade. We structure requirements, screen preliminary fit and coordinate controlled introductions; licensed counterparties make the regulated and purchasing decisions.
For licensed and otherwise authorized commercial operators. Not for patients or consumers. This page is not legal, regulatory, quality, financial or medical advice.
Identity and accountability
A named entity and a direct operating contact.
Public claims and corrections should resolve to a responsible organization and person—not an anonymous marketplace profile.
Paul Bright
For a business inquiry, source question or correction, contact paul@provenance.green.
Provenance Global Trade Network LLC
Provenance is the named editorial owner for the public methodology, guides and tools on this website and states a visible review date on substantive pages.
Scope
What Provenance does—and does not do.
Clear boundaries help buyers, suppliers and advisers assign each decision to the party that can properly make it.
Provenance does
- Capture one current buyer requirement and its mandatory criteria.
- Screen a small number of permitted capabilities against product, evidence, route, timing and comparable economics.
- Label primary evidence, counterparty statements, inferences, unknowns and stale information separately.
- Identify the smallest missing-information set needed for the next decision.
- Coordinate a controlled introduction after the applicable relationship, fee, route and disclosure gates are satisfied.
Provenance does not
- Operate a public live-inventory catalogue, product checkout or consumer service.
- Take title to, possess, import, export, transport, test, manufacture, certify or release cannabis products.
- Publish supplier identities, exact live pricing, COAs or restricted documents by default.
- Issue a legal, regulatory, quality or medical approval.
- Guarantee a match, introduction, transaction, authorization, shipment or commercial outcome.
Non-custodial means the parties transact directly. Buyers, suppliers and their appointed licensed service providers remain responsible for contracts, funds, product, shipping, import/export, manufacturing, testing, certification, release and transaction-specific professional advice.
Evidence and editorial policy
Show the source, state and date.
Our public material is intended to help professional readers ask better diligence questions. It is not a substitute for checking the current rule, registry, document or responsible professional for the actual transaction.
Primary records first
Where available, we link to the issuing authority, official law, guideline or registry. Secondary analysis may add context but does not replace the primary record.
No silent promotion to fact
A counterparty statement or working inference remains labelled. Unknown, pending, expired and stale information stays visible until the appropriate evidence supports a different state.
Specific check, specific limit
A “reviewed” date records the page review—not permanent accuracy. A registry or document check applies only to the named entity, scope and date recorded.
Corrections: email paul@provenance.green with the page URL, disputed wording and the strongest available source. Material corrections are reviewed against the source and reflected in the page text and review date where warranted.
Privacy, disclosure and conflicts
Collect less publicly. Disclose only when the gate is met.
Commercial usefulness does not require public identities or unrestricted documents.
Public intake is limited
Public forms request business and requirement information. Do not submit patient data, identity documents, COAs, certificates or confidential files through them.
Disclosure is staged
Preliminary work is internal or anonymous. Redacted evidence, identities and introductions require the applicable permission, protection and route checks.
Commercial interests are stated
Supplier payment does not determine a recommendation. Fee payer, role and material conflicts should be disclosed in the relevant opportunity terms; Provenance does not use pay-to-rank or hidden dual compensation.
See the privacy notice for website collection, storage, analytics choices, providers, retention and access/correction requests. See how we screen supply for the public evidence and disclosure method.
Primary-source starting points
Official material behind recurring diligence questions.
These links help frame checks. They do not establish that a particular entity, product, lot, route or shipment is acceptable.
- European Medicines Agency: GACP for starting materials of herbal origin — guideline, current version and revision history.
- European Commission: EudraLex Volume 4 — EU GMP guidance and annexes.
- EudraGMDP — public manufacturing/import authorization, GMP certificate and non-compliance records.
- EUR-Lex: Directive 2001/83/EC, consolidated text — EU medicinal-product framework; confirm current applicability with qualified advisers.
- Germany: Medizinal-Cannabisgesetz (MedCanG) — current consolidated federal text.
Start with demand
Bring one current buying requirement.
Provenance will return a credible-fit, missing-information or no-fit answer. No meeting is required to start.